Raja R. Seethala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Raja R. Seethala has a total of 433 co-authors. Here are the top co-authors by number of shared publications:
- Robert L. Ferris
UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania
51 shared publications - Simion I. Chiosea
Department of Pathology University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA
33 shared publications - Jennifer R. Grandis
Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, CA, USA
30 shared publications - Seungwon Kim
Department of Otolaryngology, University of Pittsburgh Medical Center, 203 Lothrop St, Pittsburgh, PA 15213, USA
27 shared publications - Umamaheswar Duvvuri
Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
26 shared publications - William E. Gooding
Biostatistics Facility, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
24 shared publications
Latest Publications
- 25 May 2026
- Published by Springer Nature in Head and Neck Pathology
- Vol. 20 (1) , 47
Caught in the Act: Intercalated Duct Lesion Associated with Adenoid Cystic Carcinoma Harboring a MYBL1::NFIB Fusion
Intercalated duct lesions (IDLs) are putative precursors notably associated with epithelial myoepithelial carcinoma and basal cell adenoma. We report the novel transition of IDL to adenoid cystic carcinoma (AdCC) in the parotid gland of a 38-year-old male. The patient presented with a longstanding mass and subsequently underwent parotidectomy. Microscopically, the 3.9 cm tumor consisted mainly of tubular/cribriform AdCC. However, the periphery showed three IDL foci with a similar immunophenotype. Next generation sequencing demonstrated a MYBL1::NFIB fusion. We thus further expand the spectrum of tumors that can transition from IDL.
- 25 May 2026
- Published by Springer Nature in Head and Neck Pathology
- Vol. 20 (1) , 47
Caught in the Act: Intercalated Duct Lesion Associated with Adenoid Cystic Carcinoma Harboring a MYBL1::NFIB Fusion
Intercalated duct lesions (IDLs) are putative precursors notably associated with epithelial myoepithelial carcinoma and basal cell adenoma. We report the novel transition of IDL to adenoid cystic carcinoma (AdCC) in the parotid gland of a 38-year-old male. The patient presented with a longstanding mass and subsequently underwent parotidectomy. Microscopically, the 3.9 cm tumor consisted mainly of tubular/cribriform AdCC. However, the periphery showed three IDL foci with a similar immunophenotype. Next generation sequencing demonstrated a MYBL1::NFIB fusion. We thus further expand the spectrum of tumors that can transition from IDL.
- 30 March 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (6) , 4905-4910
HPV-Associated Oropharyngeal Squamous Cell Carcinoma – Key Updates to the AJCC/UICC TNM9 Staging System
- 30 March 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (6) , 4905-4910
HPV-Associated Oropharyngeal Squamous Cell Carcinoma – Key Updates to the AJCC/UICC TNM9 Staging System
- 26 March 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (6) , 4964-4965
ASO Visual Abstract: Key Updates on the Version 9 AJCC/UICC Staging System for Salivary Gland Carcinoma
- 26 March 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (6) , 4964-4965
ASO Visual Abstract: Key Updates on the Version 9 AJCC/UICC Staging System for Salivary Gland Carcinoma
- Open Access
- 2 March 2026
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 58, 101141
Outcomes of patients with oral cavity squamous cell carcinomas with perineural invasion treated with adjuvant intensity modulated radiation therapy (IMRT)
- 2 March 2026
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 58, 101141
Open AccessOutcomes of patients with oral cavity squamous cell carcinomas with perineural invasion treated with adjuvant intensity modulated radiation therapy (IMRT)
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 - 2 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient tumors
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 - 2 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient tumors
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 - 1 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient lymph samples
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 - 1 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient lymph samples
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 - 1 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Orthogonal Validation of Lymph and Plasma MRD Detection.
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 - 1 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Orthogonal Validation of Lymph and Plasma MRD Detection.
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 - 2 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Orthogonal Validation of Lymph and Plasma MRD Detection.
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 - 2 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Orthogonal Validation of Lymph and Plasma MRD Detection.
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 - 2 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Lymph ctDNA outperforms pathology biomarkers.
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 - 2 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Lymph ctDNA outperforms pathology biomarkers.